Current Understanding of Spinal Pain and the Nomenclature of Lumbar Disc Pathology

Published on 10/03/2015 by admin

Filed under Neurosurgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2486 times

Chapter 2 Current Understanding of Spinal Pain and the Nomenclature of Lumbar Disc Pathology

Any structure to be deemed a cause of back pain should:

Tissues capable of transmitting pain in the back are as follows:

General pain mechanism

The two categories of pain are as follows:

Potential associations between particular mechanisms and particular symptoms are as follows:

The pain evoked by different input channels represents operation of multiple mechanisms, such as the following:

A number of different input channels can lead to the pain sensation. These should be the first anatomic targets for treatment (Fig. 2-1; Table 2.1), as follows:

The four primary types of pain (Fig. 2-2) are as follows:

BOX 2.1 Positive and Negative Symptoms of Peripheral Neuropathic Pain

Woolf CJ: Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 2004;74:2605-2610.

Adaptive pain and maladaptive pain are defined in Box 2.2.

Multiple mechanisms that can produce pain, as follows:

image

Figure 2–3 A, The peripheral terminal of a nociceptor sensory neuron. The different transducing receptor and ion channels that respond to thermal, mechanical, and chemical stimuli are shown. MDEG, mammalian degenerin; P2X, purinergic receptor; TRM3, 2’-O-ribose methyltransferase 3. B, The mechanism of peripheral sensitization. Inflammatory mediators, such as prostaglandin E2 (PGE2), bradykinin (BK), and nerve growth factor (NGF), activate intracellular kinases in the peripheral terminal that phosphorylate transducer channels to reduce their threshold or sodium channels to increase excitability. C, Transcriptional changes in the dorsal root ganglion (DRG). Activity, growth factors, and inflammatory mediators act on sensory neurons to activate intracellular transduction cascades. These cascades control the transcription factors that modulate gene expression, leading to changes in the levels of receptors, ion channels, and other functional proteins. AA, arachidonic acid; ASIC, acid-sensing ion channel; ATP, adenosine triphosphate; CaMKIV, calcium/calmodulin-dependent protein kinase IV; Cox2, cyclooxygenase-2; ERK, extracellular signal-regulated kinase; EP, prostaglandin E receptor; JNK, jun kinase; mRNA, messenger RNA; Nav1.8/1.9, voltage gated sodium channel type 1.8/1.9; NGF, nerve growth factor; P38, serinethreonine kinase; PKA, protein kinase A; PKC, protein kinase C; TRP, transient receptor potential.

(From Woolf CJ: Pain: Moving from symptom control toward mechanism-specific pharmacologic management.Ann Intern Med 2004;140:441-451.)

image

Figure 2–5 Scheme of the Major Signaling Pathways that Regulate TRP Ion Channels. (+) represents sensitization or activation; (−) represents desensitization. In the early phase of inflammation, increased pain sensitivity originates largely as a result of the local release from inflammatory cells of a number of mediators. Most of these inflammatory mediators do not directly activate nociceptors, but rather act as sensitizers, reducing the threshold of the peripheral nociceptor terminals. Among the major inflammatory mediators are prostanoids, particularly prostaglandin E2 (PGE2), bradykinin, and nerve growth factor. These chemicals acting through EP prostaglandin and B1/B2 bradykinin G protein-coupled receptors and the high-affinity TrkA NGF receptor produce their immediate effects on pain hypersensitivity locally on the nociceptor terminals by phosphorylating TRPV1 as well as the sensory neuron-specific voltage-gated sodium channel Nav 1.8. Activation of the protease-activated receptor 2 by inflammatory proteases like trypsin has a similar effect. Phosphorylation and dephosphorylation substantially alter TRPV1 ion channel function, and this represents a major means of rapidly and dynamically altering pain sensitivity. AA, arachidonic acid; AC, adenylate cyclase; AKAP, A-kinase anchor proteins; B2R, bradykinin receptor 2 (BDKRB2); CaM, calmodulin; CaMKII, calmodulin dependent kinase II; COX, cyclooxygenase; DAG, diacylglycerol; EET, epoxyeicosatrienoic acids; EP, prostaglandin E; ER, endoplasmic reticulum; ERK, extracellular-signal-regulated kinases; G11, guanine nucleotide-binding (G) protein-subunits 11; HPETE, hydroperoxyeicosatetraenoic acid; IP3R, inositol 1,4,5-trisphosphate receptor; LOX, lipooxygenase; NGF, nerve growth factor; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PI3K, phosphatidylinositol 3-kinases; PKA, protein kinase A; PKC, protein kinase C; PLA2, phospholipases A2; PLC, phospholipase C; PP2B, protein phosphatase 2B (Calcineurin (CN)); P38, mitogen-activated protein kinases; P450, cytochrome P450; Src, a family of proto-oncogenic tyrosine kinases, Rous sarcoma virus (RSV); Trk A, tyrosine kinase A; TRP, transient receptor potential (has TRPV, TRPM, TRPA, and TRPC subfamilies).

(Modified from Wang H, Woolf CJ. Pain TRPs. Neuron 2005;46:9-12.)

Ectopic excitability, structural reorganization, and decreased inhibition are unique to neuropathic pain, whereas peripheral sensitization occurs in inflammatory pain and in some forms of neuropathic pain.

Pain transient receptor potential (TRP) ion channels are listed in Table 2.2 and illustrated in Figure 2-6. TRP ion channels are molecular gateways in sensory systems, an interface between the environment and the nervous system. Several TRPs transduce thermal, chemical, and mechanical stimuli into inward currents, an essential first step in eliciting thermal and pain sensations.

Facet joint pain

Innervations

The nerve roots are invested by pia mater and covered by arachnoid and dura as far as the spinal nerve. The dura of the dural sac continues around the roots as their dural sleeve, which blends with the epineurium of the spinal nerve (Fig. 2-7).

image

Figure 2–7 Spinal nerves.

(From Schuenke M, Schulte E, Schumacher U, et al [eds]: Thieme Atlas of Anatomy: General Anatomy and Musculoskeletal System. Stuttgart, Thieme, 2006, p 62.)

Facet joints are well innervated by the medial branches of the dorsal rami, which contain free and encapsulated nerve endings as well as nociceptors and mechanoreceptors. Each segmental medial branch of the dorsal ramus supplies at least two (in humans, monkeys, and cats) or three (in rats) facet joints (Table 2.3).

Situations that can lead to pain upon facet joint motion are degeneration, inflammation, and injury of the facet joint.

Pain leads to restriction of motion, which eventually leads to overall physical deconditioning. Irritation of the facet joint innervation in itself also leads to secondary muscle spasm.

The facet has extensive innervation of the synovial lining by small C-type pain fibers, as evidenced by the following findings:

Intervertebral disc

The three components of the intervertebral disc (IVD) are as follows:

Distinguishing “Normal Aging” from Disease of the Intervertebral Disc

Figures 2-8 and 2-9 and Table 2.4 contain information pertinent to this issue.

image

Figure 2–8 Questionable radiographic diagnoses that increase in frequency with age, from imaging studies of patients without symptoms. CT, computed tomography; DJD, degenerative joint disease; MRI, magnetic resonance imaging.

(From Loeser JD: Low back pain. In Loeser JD, Butler SH, Chapman CR, Turk DC [eds]: Bonica’s Management of Pain, 3rd ed. Philadelphia, Lippincott Williams & Wilkins, 2001, p 1520.)

image

Figure 2–9 Forces within the nucleus pulposus and annulus of a nondegenerated disc (left) and degenerated disc (right) under compression.

(From Urban JPG, Roberts S: The intervertebral disc: Normal, aging, and pathologic. In Herkowitz HN, Garfin SR, Eismont FJ, et al [eds]: Rothman-Simeone The Spine, 5th ed. Philadelphia, Saunders, 2006, p 133.)

Table 2.4 Pathophysiology of Intervertebral Disc Aging and Degeneration

Process Effects
Diminished cellular response Senescence (alteration in gene expression and transcription factors)
  Apoptosis (programmed cell death)
Biochemical processes Imbalance between catabolic and anabolic activity:

End plate changes Diminished vascularity and decreased porosity because of end plate calcification → elevated lactate concentrations and reduced pH → cell apoptosis   Thinning or microfracture of the end plate → increased permeability and altered hydraulic property → nonuniform load transference and increased focal shear stress → disc degeneration and anular damage

From Biyani A, Andersson GBJ: Low back pain: Pathophysiology and management.J Am Acad Orthop Surg 2004;12:106-115.

Altered Matrix Composition and Integrity

Normal discal chondrocytes are characterized by expression of type II collagen and proteoglycans and are regulated by the “master chondroregulatory gene,” SOX-9. In cases of disc degeneration, increased synthesis of collagens I and III and decreased production of aggrecan are noted. Furthermore, the regulation of matrix turnover is deranged, affecting both synthesis and degradation. There is a net increase in matrix-degrading enzyme activity over natural inhibitors of such activity, which leads to loss of discal matrix. Particular attention has been paid to the role of matrix metalloproteinases (MMPs) in these processes, making them a potential target for therapy designed to inhibit disc degeneration.

After work on the mechanism of aggrecan degradation in articular cartilage, interest has now grown in the possible role of aggrecanases in IVD degeneration. Aggrecan has two cleavage sites, one acted upon by MMPs and the other by members of a group of enzymes called the ADAMs family (after their hybrid function, a disintegrin and metalloproteinase). In fact, the aggrecanases are two enzymes, ADAMTS4 and ADAMTS5, that in addition to their disintegrin and metalloproteinase function also have thrombospondin motifs (hence the TS). From the pathologic perspective, these studies have largely been undertaken, not by looking for the enzymes themselves, but through the application of antibodies targeted at the breakdown product of aggrecan formed by enzyme action at the specific site.

Nerve and Blood Vessel Ingrowth

Although the normal adult IVD is avascular and aneural, nerves and blood vessels grow into diseased IVD. One avenue of investigation has been the local production of angiogenic and neurogenic molecules within degenerate IVD (Fig. 2-10), which has yielded the following findings:

image

Figure 2–10 Schematic view of the routes for nutrient transport into the avascular disc and resulting nutrient profiles.

(Reprinted from Urban JPG, Roberts S: The intervertebral disc: Normal, aging, and pathologic. In Herkowitz HN, Garfin SR, Eismont FJ, et al [eds]: Rothman-Simeone The Spine, 5th ed. Philadelphia, Saunders, 2006, p 77.)

The implication of these findings is that although either angiogenesis or neuronogenesis could be targets for therapy, angiogenesis drives nerve ingrowth and may be more significant from a therapeutic perspective.

Cytokines as regulators of disease processes

There has also been growing interest in the possible role of cytokines in regulating the connective tissue degradation, nerve and vessel ingrowth, and macrophage accumulation that characterize IVD degeneration (Table 2.5) [4,5]. A number of cytokines have been implicated, including TNF (tumor necrosis factor) (Fig. 2-11), IL-1 (interleukin-1), IL-6, and IL-10, PDGF (platelet-derived growth factor), VEGF (vascular endothelial growth factor), IGF-1 (insulin-like growth factor-1), TGF-β (transforming growth factor-β), EGF (epidermal growth factor), and FGF (fibroblast growth factor) [6].

Table 2.5 Common Chemical Substances and Their Functions

Chemical Substance Function
Phospholipase A2 Mediates mechanical hyperalgesia
Nitric oxide Inhibits mechanical hyperalgesia and produces thermal hyperalgesia
MMP-2 (gelatinase A) and MMP-9 (gelatinase)

MMP-1 (collagenase-1) Degrades collagen MMP-3 (stromelysin-1) Both MMP-1 and MMP-2 may play a role in spontaneous regression of the herniated disc IL-1, TNF-α, prostaglandin E2

Calcitonin gene–related peptide, glutamate, substance P (neurotransmitters) Modulate dorsal root ganglion responses IL-6 Induces synthesis of TIMP-1 TIMP-1 Inhibits MMPs Transforming growth factor-β superfamily Blocks synthesis of MMPs Insulin-like growth factor-1, platelet-derived growth factor Have an anti-apoptotic effect

IL, interleukin; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase.

From Biyani A, Andersson GBJ: Low back pain: Pathophysiology and management.J Am Acad Orthop Surg 2004;12:106-115.

Studies of IL-1 have yielded the following findings:

As IL-1 is the regulator of cartilage catabolism, the TGF-β superfamily is the regulator of cartilage anabolism. A twofold increase was seen in proteoglycan synthesis by rabbit nucleus pulposus cells after injection of rabbit intervertebral discs with an adenoviral vector carrying a human TGF-β transgene [6].

Nomenclature and classification of lumbar disc pathology

The North American Spine Society (NASS), the American Society of Spine Radiology (ASSR), and the American Society of Neuroradiology (ASNR) have determined nomenclature for and classification of lumbar disc pathology, which are summarized here.

General classifications of disc lesions are listed in Box 2.3 and described here:

Herniation: Herniation is defined as a localized displacement of disc material beyond the limits of the intervertebral disc space (Fig. 2-14). Disc material may be nucleus, cartilage, fragmented apophyseal bone, anular tissue, or any combination thereof.
image

Figure 2–14 Herniated disc refers to localized displacement of nucleus, cartilage, fragmented apophyseal bone, or fragmented anular tissue beyond the intervertebral disc space (disc space, interspace). The interspace is defined, craniad and caudad, by the vertebral body end plates. Two intravertebral herniations, one with an upward orientation and the other with a downward orientation with respect to the disc space, are illustrated schematically.

(Adapted from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93-E113.)

Classifications of Disc Herniation

Figure 2-15 illustrates, and Box 2.4 summarizes, the proposed categories for the description and classification of disc herniation, which are as follows [7]:

image

Figure 2–15 The interspace is defined, peripherally, by the edges of the vertebral ring apophyses, exclusive of osteophytic formations. A, The line drawing schematically illustrates a localized extension of disc material beyond the intervertebral disc space, in a left posterior direction, which qualifies as a disc herniation. B, For classification purposes, the intervertebral disc is considered a two-dimensional round or oval structure having four 90-degree quadrants. By convention, a herniation is a localized process involving less than 50% (180 degrees) of the disc circumference. C, By convention, a focal herniation involves less than 25% (90 degrees) of the disc circumference. D, By convention, a broad-based herniation involves between 25% and 50% (90 to 180 degrees) of the disc circumference. E, Symmetrical presence (or apparent presence) of disc tissue circumferentially (50%-100%) beyond the edges of the ring apophyses may be described as a “bulging disc” or “bulging appearance” and is not considered a form of herniation. Furthermore, bulging is a descriptive term for the shape of the disc contour and not a diagnostic category. F, Asymmetrical bulging of the disc margin (50%-100%), such as found in severe scoliosis, is also not considered a form of herniation. Herniated discs may take the form of protrusion (G) or extrusion (H), according to the shape of the displaced material.

(Adapted from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93-E113.)

BOX 2.4 Proposed Categories for Description and Classification of a Disc Herniation

Modified from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2003;26:E93-E113.

Bulging disc, which is defined as the presence of disc tissue “circumferentially” (50%-100%) beyond the edges of the ring, is not considered a form of herniation, nor are diffuse adaptive alterations of disc contour secondary to an adjacent deformity as may be present in severe scoliosis or spondylolisthesis.

The distinction between protrusion and extrusion of a disc herniation is clarified by Figures 2-16 and 2-17.

Complications of herniated discs are illustrated in Figure 2-18.

Figures 2-19 through 2-22 summarize the nomenclature for the anatomic zones and levels of the spine.

image

Figure 2–19 Coronal drawing illustrating the main anatomic zones and levels of a spinal segment.

(Adapted from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93-E113.)

image

Figure 2–20 Schematic representation of the anatomic zones of the vertebral body identified on axial images. The anterior zone (not shown) is delineated from the extraforaminal zone by an imaginary coronal line in the center of the vertebral body.

(Adapted from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93-E113.)

image

Figure 2–21 Schematic representation of the anatomic levels of a spinal segment identified on craniocaudal images.

(Adapted from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93-E113.)

image

Figure 2–22 Schematic summative representation of anatomic levels and zones of a spinal segment.

(Adapted from Fardon DF, Milette PC; Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology: Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93-E113.)

Postlaminectomy syndrome

Animal models of postlaminectomy syndrome demonstrate paraspinous muscle spasms, tail contractures, behavioral pain behaviors, tactile allodynia, epidural and perineural scarring, and adherence of the nerve root to the underlying disc and pedicle.

Suggested causes of postlaminectomy syndrome include acquired stenosis, adjacent segment degeneration, internal disc disruption, recurrent disc herniation, retained disc fragment, spondylolisthesis, epidural or intraneural fibrosis, degenerative disc disease, radiculopathy, radicular pain, deconditioning, facet joint pain, sacroiliac joint pain, discitis, arachnoiditis, pseudoarthrosis, and segmental instability. Among these, etiologies such as epidural fibrosis, facet joint dysfunction, sacroiliac dysfunction, internal disc dysfunction, recurrent disc herniation, and spinal stenosis can be treated by interventional pain techniques. Ultimately, many of these causes are interrelated.

Facet joint involvement in chronic pain following lumbar surgery has been shown to be present in approximately 8% to 16% of patients. Through the use of a single nerve block, one study found the prevalence of sacroiliac joint pain following lumbar fusion to be 35% [8].

Epidural fibrosis may occur after an annular tear, disc herniation, hematoma, infection, surgical trauma, vascular abnormalities, or intrathecal injection of contrast media. Epidural fibrosis may account for as much as 20% to 36% of all cases of failed back surgery syndrome. Alternatively, there may be a final common pathway for all these etiologies that results in peripheral and central facilitation potentiated by inflammatory and nerve injury mechanisms. Paraspinal muscles may also become denervated and involved in the pathogenesis of failed back surgery syndrome [8].

References

1 Manchukonda R., Manchikanti K.N., Cash K.A., et al. Facet joint pain in chronic spinal pain: An evaluation of prevalence and false-positive rate of diagnostic blocks. J Spinal Disord Tech. 2007;20:539-545.

2 Kallakuri S., Singh A., Chen C., Cavanaugh J.M. Demonstration of substance P, calcitonin gene-related peptide, and protein gene product 9.5 containing nerve fibers in human cervical facet joint capsules. Spine. 2004;29:1182-1186.

3 Freemont A.J., Watkins A., Le Maitre C., et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002;197:282-286.

4 Biyani A., Andersson G.B.J. Low back pain: Pathophysiology and management. J Am Acad Orthop Surg. 2004;12:106-115.

5 Freemont A.J., Watkins A., Le Maitre C., et al. Current understanding of cellular and molecular events in intervertebral disc degeneration: Implications for therapy. J Pathol. 2002;196:374-379.

6 Nishida K., Kang J.D., Gilbertson L.G., et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine. 1999;24:2419-2425.

7 Fardon D.F., Milette P.C., Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Nomenclature and classification of lumbar disc pathology: Recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine. 2003;26:E93-E113.

8 Boswell M.V., Shah R.V., Everett C.R., et al. Interventional techniques in the management of chronic spinal pain: Evidence-based practice guidelines. Pain Physician. 2005;8:1-47.